Skip to content

Early Oral Hydration After Thoracoscopic Surgery

Safety and Feasibility of Early Oral Hydration After Video-assisted Thoracoscopic Surgery: A Prospective, Randomized, and Controlled Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06297720
Enrollment
120
Registered
2024-03-07
Start date
2024-03-01
Completion date
2025-06-30
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Intubation Complication

Keywords

Early oral hydration, Sore throat

Brief summary

The goal of this clinical trial is to learn about the safety and feasibility of early oral hydration in patients receiving video-assisted thoracoscopic surgery after general anesthesia. The main questions aims to answer: * the safety and feasibility of oral hydration supplementation in the recovery room following general anesthesia. * the degree of improvement in sore throat and dry mouth after oral hydration. * the side effects and risks of oral hydration supplementation, such as the incidence of postoperative nausea and vomiting. * the impact of oral hydration supplementation in the recovery room following general anesthesia on hemodynamics. * patient satisfaction with oral hydration supplementation in the recovery room following general anesthesia. Participants will receive a series of oral hydration from swab moistening, and ice cube hydration to water hydration in the recovery room. Researchers will compare with the standard, no-hydration group to see if it is safe and feasible to hydrate patients in the recovery room.

Detailed description

Anesthesiologists assess the removal of the endotracheal tube post-surgery and the patient is then transferred to the recovery room for rest. The principal investigator will evaluate the consciousness status and risk of nausea and vomiting to confirm eligibility for the trial. Subsequently, the following grouping will be conducted: 1. Experimental group * First, moisten the patient's throat with a cotton swab dipped in water. If no nausea or vomiting occurs after five minutes, proceed to the next stage. * Provide an ice cube for the patient to hold in their mouth. If no nausea or vomiting occurs after ten minutes, proceed to the next stage. * Offer 10-20ml water for the patient to drink under medical supervision. If no nausea or vomiting occurs and the patient requests more water, administer 10-20ml of water every ten minutes, assessing for any adverse effects each time. The total water intake should not exceed 500ml. 2. Comparison group - standard care without any intervention Evaluate the level of throat pain using VAS (Visual Analogue Scale) score, the incidence, timing, frequency of post-operative nausea and vomiting, the level of mouth dryness, the satisfaction of patients in recovery room, and the vital signs.

Interventions

BEHAVIORALOral hydration

* Researchers moisten the patient's throat with a wet cotton swab. If no nausea or vomiting occurs after five minutes, proceed to the next stage. * Provide an ice cube of potable water for the patient to hold in their mouth. If no nausea or vomiting occurs after ten minutes, proceed to the next stage. * Offer 10-20ml of potable water for the patient to drink under medical supervision. If no nausea or vomiting occurs and the patient requests more water, administer 10-20ml every ten minutes, assessing for any adverse effects each time. The total water intake should not exceed 500ml.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females aged 18 to 70. * Anesthesia physical status classification III or below * Body Mass Index 30 or below * Elective video-assisted thoracoscopic surgery

Exclusion criteria

* Pre-operative throat pain * Impaired mental status * Tendency to choke (inc. dysphagia, stroke hx.) * Nil Per Os (NPO) less than 8 hours * Pregnancy * Nausea and vomiting in Operating room or Post-anesthesia care unit

Design outcomes

Primary

MeasureTime frameDescription
sore throat level by VAS (Visual Analogue Scale)From patient arrived at the PACU (Postanesthesia Care Unit) to patient being discharged, about 1-3 hourssore throat level by VAS (Visual Analogue Scale) measured by 0-10 point-scale
Mouth drynessFrom patient arrived at the PACU (Postanesthesia Care Unit) to patient being discharged, about 1-3 hoursModified Schirmer tear strip test

Secondary

MeasureTime frameDescription
post-operative nausea and vomiting (PONV)From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hoursPONV exist or not
timing of post-operative nausea and vomiting (PONV)From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hoursPONV or not, if yes, record timing
duration of post-operative nausea and vomiting (PONV)From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hoursPONV or not, if yes, record duration
management of post-operative nausea and vomiting (PONV)From patient been sent to PACU (Postanesthesia Care Unit) until discharge, about 1-3 hoursPONV or not, if yes, record management
Heart Rate in PACU (Postanesthesia Care Unit)From patient been sent to PACU (Postanesthesia Care Unit) until discharge in every 5 minutes, about 1-3 hoursHeart Rate (/min) in PACU (Postanesthesia Care Unit)
Blood pressure in PACU (Postanesthesia Care Unit)From patient been sent to PACU (Postanesthesia Care Unit) until discharge in every 5 minutes, about 1-3 hoursBlood pressure (mmHg) in PACU (Postanesthesia Care Unit)
Patient's satisfactionThrough study completion, before patients leaving PACU (Postanesthesia Care Unit)Patient's satisfaction measured by Likert scale (1-5)

Countries

Taiwan

Contacts

Primary ContactTing Ting Wang, Master
ttwang94anes@gmail.com+886978316935

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026